Printer Friendly

Browse Multiple sclerosis topic

Drug therapy subtopic

Articles

1-300 out of 414 article(s) nextnext page
Title Author Type Date Words
AbbVie gets FDA orphan drug, fast tract designations for elezanumab. Sep 28, 2020 174
Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis. Daniels, K.; van der Nat, P.B.; Frequin, S.T.F.M.; van der Wees, P.J.; Biesma, D.H.; Hoogervorst, E. Jun 30, 2020 3445
Prime Therapeutics signs value-based contract with EMD Serono. Jun 9, 2020 216
Prime Therapeutics signs value-based contract with EMD Serono. Jun 9, 2020 212
BAFIERTAM RECEIVES FINAL FDA APPROVAL FOR MS. May 27, 2020 463
Banner Life Sciences Announces Final FDA Approval of Bafiertam for Multiple Sclerosis. Apr 30, 2020 327
US Food and Drug Administration Approves Bristol Myers Squibb's Zeposia for Relapsing Forms of Multiple Sclerosis. Mar 26, 2020 1013
Approval Nears for MS Drug. Mar 16, 2020 720
Novartis Files Two Applications For Multiple Sclerosis Drug Ofatumumab. Feb 24, 2020 346
Drug Makers Get Nod for Generic fingolimod. Feb 17, 2020 388
Study tests immunotherapy in people with cancer and autoimmune diseases. Feb 1, 2020 1531
Multiple Sclerosis Treatment Market Is Projected to Grow at a CAGR of 3.5% By 2023. Jan 21, 2020 663
FDA Approves First Generic Forms of MS Drug Gilenya. Dec 6, 2019 314
Biogen Presents Data Demonstrating Improved Gastrointestinal Tolerability With VUMERITY[TM] (diroximel fumarate) Compared to TECFIDERA[R] (dimethyl fumarate). Nov 22, 2019 1817
Magenta Therapeutics Presents First Immune Reset Results with Antibody-Drug Conjugate Across Multiple Autoimmune Diseases at ACR. Nov 13, 2019 445
NHS approves cannabis-based drugs to tackle MS and epilepsy symptoms; Epidyolex approved for two rare types of epilepsy, Lennox-Gastaut and Dravet syndromes, while the spray Sativex has been recommended for muscle spasms in multiple sclerosis. Brett Gibbons Nov 11, 2019 689
Cannabis backed for use on the NHS -but campaigners slam 'missed opportunity'; Two medicines have been approved for use, but the idea of prescribing cannabis drugs to treat chronic pain has been ruled out. By, Amy Coles Nov 11, 2019 265
NHS approves cannabis-based drugs to tackle MS and epilepsy symptoms; Epidyolex approved for two rare types of epilepsy, Lennox-Gastaut and Dravet syndromes, while the spray Sativex has been recommended for muscle spasms in multiple sclerosis. Brett Gibbons Nov 11, 2019 689
NHS approves cannabis-based drugs to tackle MS and epilepsy symptoms; Epidyolex approved for two rare types of epilepsy, Lennox-Gastaut and Dravet syndromes, while the spray Sativex has been recommended for muscle spasms in multiple sclerosis. Brett Gibbons Nov 11, 2019 689
NHS approves cannabis-based drugs to tackle MS and epilepsy symptoms; Epidyolex approved for two rare types of epilepsy, Lennox-Gastaut and Dravet syndromes, while the spray Sativex has been recommended for muscle spasms in multiple sclerosis. Brett Gibbons Nov 11, 2019 689
NHS approves cannabis-based drugs to tackle MS and epilepsy symptoms; Epidyolex approved for two rare types of epilepsy, Lennox-Gastaut and Dravet syndromes, while the spray Sativex has been recommended for muscle spasms in multiple sclerosis. Brett Gibbons Nov 11, 2019 689
NHS approves cannabis-based drugs to tackle MS and epilepsy symptoms; Epidyolex approved for two rare types of epilepsy, Lennox-Gastaut and Dravet syndromes, while the spray Sativex has been recommended for muscle spasms in multiple sclerosis. Brett Gibbons Nov 11, 2019 689
Biogen Idee (NASDAQ: BIIB) - Biogen and Alkermes Announce FDA Approval of VUMERITY[TM] (diroximel fumarate) for Multiple Sclerosis -- 30/10/2019. Nov 6, 2019 661
Assessment of safety and effectiveness of oral multiple sclerosis medication. Turaiki, Abdulrahman M. Al; Ammari, Maha A. Al; Alabdulkarim, Dalal A.; Althemery, Abdullah U. Nov 1, 2019 4584
Biogen Inc & Alkermes plc partnership wins FDA approval for VUMERITY for treating relapsing forms of MS. Oct 31, 2019 314
Biogen Inc & Alkermes plc partnership wins FDA approval for VUMERITY for treating relapsing forms of MS. Oct 31, 2019 310
Biogen and Alkermes Announce FDA Approval of VUMERITY[TM] (diroximel fumarate) for Multiple Sclerosis. Oct 30, 2019 3467
Biogen, Alkermes announce FDA approval of VUMERITY for multiple sclerosis. Oct 30, 2019 297
Multiple Sclerosis Treatment Market 2019 Classification, Application, Industry Chain Overview, SWOT Analysis and Competitive Landscape To 2023. Oct 22, 2019 1012
More cancer drugs confirmed - even more on horizon. Oct 7, 2019 310
Multiple Sclerosis Diagnosis and Management: A simple Literature Review. Alshammari, Yazeed Hamoud Mutlaq; Aldoghmi, Amjad Kamayan B.; Afif, Heba Sadiq A. Al; Alfayi, Banan Disease/Disorder overview Oct 1, 2019 3860
Anokion Presents New Data Describing Transformative Therapeutic Approach for Treatment of Multiple Sclerosis at ECTRIMS Congress. Sep 18, 2019 368
Roche's Ocrevus Multiple Sclerosis Drug Shows Continuous Use Benefit. Sep 13, 2019 203
Celgene Corporation (NASDAQ: CELG) - Data from Ozanimod Clinical Development Program in Relapsing Forms of Multiple Sclerosis to Be Presented at the 35th Congress of the European Committee for Treatment and Research in Multiple Sclerosis -- 9/9/2019. Sep 12, 2019 822
Alexion Pharmaceuticals (NASDAQ: ALXN) - Alexion Announces Upcoming Data Presentations At 35th Congress Of The European Committee For Treatment And Research In Multiple Sclerosis -- 28/8/2019. Sep 5, 2019 415
Translation and Validation of the Turkish Version of Multiple Sclerosis Treatment Adherence Questionnaire (MS-TAQ). Yesilbalkan, Oznur Usta; Erbay, Oznur; Yuceyar, Ayse Nur Sep 1, 2019 3171
The Daily Biotech Pulse: Genmab-Novartis Multiple Sclerosis Drug Aces Late-Stage Studies, Akari Nets Orphan Drug Designation. Aug 30, 2019 587
Alexion Pharmaceuticals (NASDAQ: ALXN) - Alexion Announces Upcoming Data Presentations At 35th Congress Of The European Committee For Treatment And Research In Multiple Sclerosis -- 28/8/2019. Aug 29, 2019 415
Regular Vaccines Advised With Multiple Sclerosis. Report Aug 28, 2019 368
For Medicare Patients, Costs of MS Drugs Rise Sevenfold Over 10 Years. Norton, Amy Aug 28, 2019 783
MP MAKES CANNABIS LAW VOW; Pledge over medicinal use of drug. Aug 17, 2019 287
Selma Blair flaunts shaved head after being discharged from multiple sclerosis treatment. Jul 26, 2019 333
The Adverse Effects of High-dose Corticosteroids with Early and Late Severe Morbidity in the Treatment of Patients with Multiple Sclerosis: Long-term Observation Results/Multipl Skleroz Hastalarinin Atak Tedavisinde Yuksek Doz Kortikosteroid Kullaniminin Erken ve Gec Donem Agir Morbiditeye Yol Acan Yan Etkileri: Uzun Donem Gozlem Sonuclari. Omerhoca, Sami; Akkag, Sinem Yazici; Hasimoglu, Zerrin Yildirim; Erdogan, Sebatiye; Kale, Nilufer Jun 1, 2019 3118
FDA Approves New MS Drugs. Jun 1, 2019 174
Sutter Health, UPMC, and DNAnexus Initiate Collaboration to Improve Personalized Treatments for People with Multiple Sclerosis. Apr 17, 2019 752
The US FDA authorises new oral treatment Mavenclad for multiple sclerosis. Apr 1, 2019 243
The US FDA authorises new oral treatment Mavenclad for multiple sclerosis. Apr 1, 2019 239
US Food and Drug Administration approves Novartis' Mayzent. Mar 28, 2019 173
US Food and Drug Administration approves Novartis' Mayzent. Mar 28, 2019 169
Osmotica sinks 40% after multiple sclerosis drug fails to beat placebo. Mar 28, 2019 351
Novartis wins US FDA approval for Mayzent to treat multiple sclerosis patients. Mar 27, 2019 350
Novartis wins US FDA approval for Mayzent to treat multiple sclerosis patients. Mar 27, 2019 346
Novartis receives FDA approval for multiple sclerosis treatment Mayzent. Mar 27, 2019 168
Celgene Submits Seeks European Medicines Nod for Ozanimod as Treatment of Relapsing-Remitting Multiple Sclerosis. Disease/Disorder overview Mar 11, 2019 591
Strokes, arterial dissections reported with alemtuzumab, FDA says. Splete, Heidi Feb 1, 2019 349
Efficacy and Safety of Teriflunomide in Chinese Patients with Relapsing Forms of Multiple Sclerosis: A Subgroup Analysis of the Phase 3 TOWER Study. Qiu, Wei; Huang, De-Hui; Hou, Shi-Fang; Zhang, Mei-Ni; Jin, Tao; Dong, Hui-Qing; Peng, Hua; Zhang, C Report Dec 5, 2018 4795
Evidence thin on medical marijuana, EU illegal drugs body says. Dec 4, 2018 306
Non-Invasive Treatment May Help Multiple Sclerosis Patients. Sep 1, 2018 112
MS drug is recommended by officials; Health. Jun 22, 2018 184
Withdrawn multiple sclerosis drug not used in Cyprus, ministry says. May 24, 2018 216
EMA rules risks associated with MS drug Zinbryta outweigh the benefits. May 22, 2018 238
EMA rules risks associated with MS drug Zinbryta outweigh the benefits. May 22, 2018 242
Gilenya Approval Expanded to Include Treatment of MS in Pediatric Patients. May 16, 2018 249
Mylan partners with Mapi on new MS drug. May 14, 2018 105
FDA Expands Use of MS Drug to Include Children; Gilenya is the first multiple sclerosis drug approved for children. May 14, 2018 179
Guidelines Developed for Use of Drugs in Multiple Sclerosis; Guidelines relate to starting, switching, stopping disease-modifying therapies. Apr 24, 2018 300
Merck's drug for multiple sclerosis wins UAE approval. Apr 9, 2018 315
UAE introduces breakthrough medicine for Multiple Sclerosis. Apr 9, 2018 552
US Food and Drug Administration rejects Celgene's new drug application for ozanimod. Mar 1, 2018 235
US Food and Drug Administration rejects Celgene's new drug application for ozanimod. Mar 1, 2018 231
Celgene slides after FDA refuses filing for potential multiple sclerosis drug. Feb 28, 2018 458
Sandoz Launches Glatopa 40 mg/mL Generic for Relapsing MS. Feb 15, 2018 179
Sandoz unveils generic Glatopa 40 mg/ml three times-a-week for relapsing forms of multiple sclerosis. Feb 13, 2018 242
Sandoz unveils generic Glatopa 40 mg/ml three times-a-week for relapsing forms of multiple sclerosis. Feb 13, 2018 238
What Are the Participants' Perspectives of Taking Melatonin for the Treatment of Nocturia in Multiple Sclerosis? A Qualitative Study Embedded within a Double-Blind RCT. Khan, Rafiyah; Uren, Alan; Canham, Luke; Cottrell, David; Drake, Marcus J.; Cotterill, Nikki Clinical report Jan 1, 2018 5554
'I have it sprinkled on cheese on toast' Gran left in agony due to MS explains how she relies on cannabis; Sue Cox is one of a growing number of people calling for the medicinal use of the drug to be legalised. Dec 30, 2017 1113
Biogen and Alkermes Partner to Advance Oral Fumarate Therapy for Treatment of Multiple Sclerosis. Disease/Disorder overview Nov 29, 2017 392
Sclerosis drug, a new weapon against superbugs. Nov 23, 2017 364
Celgene Releases Efficacy, Safety Results from SUNBEAM Trial of Oral Ozanimod versus Interferon Beta-1a in Relapsing Multiple Sclerosis. Oct 30, 2017 203
Effect of Cordyceps sinensis on the Treatment of Experimental Autoimmune Encephalomyelitis: A Pilot Study on Mice Model. Zhong, Shan-Shan; Xiang, Ya-Juan; Liu, Pen-Ju; He, Yang; Yang, Ting-Ting; Wang, Yang-Yang; Rong, A.; Report Oct 5, 2017 3278
Mylan wins US FDA approval for first generic MS Copaxone injection and may be eligible for 180-day exclusivity. Oct 4, 2017 294
Mylan wins US FDA approval for first generic MS Copaxone injection and may be eligible for 180-day exclusivity. Oct 4, 2017 290
MS drug previously blocked by EU regulators found to be effective. Aug 18, 2017 517
MS drug previously blocked by EU regulators found to be effective. Aug 18, 2017 513
'MS patients struggling to get cannabis-based drug'. Jul 6, 2017 1027
Ocular manifestations of drugs used to treat multiple sclerosis. Heath, Greg Report Jul 1, 2017 4156
FDA approves MS drug. Jun 1, 2017 496
UK researchers begin Phase III trial to investigate statin's potential in MS treatment. May 9, 2017 260
UK researchers begin Phase III trial to investigate statin's potential in MS treatment. May 9, 2017 256
Novel drugs approved in 2016. Briggs, Gerald G. Apr 1, 2017 1979
Efficacy of different durations of intravenous methylprednisolone treatment in relapses of multiple sclerosis. Kulu, Ugur; Tiftikcioglu, Bedile Irem; Zorlu, Yasar; Cetiner, Mustafa; Sener, Ufuk; Tuna, Gamze; Kir Report Mar 1, 2017 4167
Sanofi partners with ImmuNext to develop treatments for autoimmune diseases. Jan 10, 2017 204
Sanofi partners with ImmuNext to develop treatments for autoimmune diseases. Jan 10, 2017 200
Natalizumab Treatment Modulates Peroxisome Proliferator-Activated Receptors Expression in Women with Multiple Sclerosis. Ferret-Sena, Veronique; Silva, Alexandra Maia e.; Sena, Armando; Cavaleiro, Ines; Vale, Jose; Deruda Report Jan 1, 2017 2996
Depression Treatment among Adults with Multiple Sclerosis and Depression in Ambulatory Care Settings in the United States. Bhattacharjee, Sandipan; Goldstone, Lisa; Ip, Queeny; Warholak, Terri Report Jan 1, 2017 5515
Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives. Coyle, Patricia K. Report Jan 1, 2017 7455
Targeting Oxidative Stress for Treatment of Glaucoma and Optic Neuritis. Kimura, Atsuko; Namekata, Kazuhiko; Guo, Xiaoli; Noro, Takahiko; Harada, Chikako; Harada, Takayuki Report Jan 1, 2017 6022
Assessment of Serum Nitrogen Species and Inflammatory Parameters in Relapsing-Remitting Multiple Sclerosis Patients Treated with Different Therapeutic Approaches. Niedziela, Natalia; Adamczyk-Sowa, Monika; Niedziela, Jacek T.; Mazur, Bogdan; Kluczewska, Ewa; Sowa Report Jan 1, 2017 8736
Man grew PS30k of cannabis to help sick mum; LOVING SON SET UP DRUG FARM TO TREAT WOMAN WITH MULTIPLE SCLEROSIS. Oct 22, 2016 359
Iran Launches Production Line of MS Drug in Russia. Sep 28, 2016 303
Iran Unveils 8 Technological Achievements, 2 New MS, Diabetes Drugs. Aug 30, 2016 213
EC approves Biogen and AbbVie's multiple sclerosis drug Zinbryta. Jul 6, 2016 167
EC approves Biogen and AbbVie's multiple sclerosis drug Zinbryta. Jul 6, 2016 163
FDA APPROVES ONCE-MONTHLY ZINBRYTA FOR MS. Jul 1, 2016 1030
Newer drugs keep multiple sclerosis patients out of wheelchairs--expert. Bateman, Chris Report Jun 1, 2016 437
MS drugs appear safe: new data support safety of three types of drugs in early pregnancy. London, Susan Medical condition overview Jun 1, 2016 1723
MS drugs deemed safe before, during pregnancy. London, Susan Medical condition overview Jun 1, 2016 1523
Biogen & AbbVie partnership wins US FDA approval for ZINBRYTA for treating multiple sclerosis. May 30, 2016 288
Biogen & AbbVie partnership wins US FDA approval for ZINBRYTA for treating multiple sclerosis. May 30, 2016 284
INNOVATIVE THERAPIES REDEFINE TREATMENT GOALS IN MULTIPLE SCLEROSIS. Lazibat, Ines; Samija, Radenka Kuzmanic; Rotim, Kresimir Report Mar 1, 2016 4380
New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis. Adamczyk, Bozena; Adamczyk-Sowa, Monika Disease/Disorder overview Jan 1, 2016 13491
Serum gelatinases levels in multiple sclerosis patients during 21 months of natalizumab therapy. Castellazzi, Massimiliano; Bellini, Tiziana; Trentini, Alessandro; Delbue, Serena; Elia, Francesca; Report Jan 1, 2016 4625
Evaluation of the adherence to immunmodulatory treatment in patients with multiple sclerosis. Koskderelioglu, Asli; Gedizlioglu, Muhtesem; Ortan, Pinar; Ocek, Ozge Report Dec 1, 2015 2925
Biogen's Phase III ASCEND study investigating natalizumab in the treatment of secondary progressive multiple sclerosis (SPMS) did not achieve its primary and secondary endpoints. Nov 1, 2015 176
New Hope for Treatment of Multiple Sclerosis. Oct 26, 2015 487
US FDA Clears Bayer's Betaconnect Electronic Autoinjector in Relapsing-Remitting Multiple Sclerosis Treatment. Sep 25, 2015 254
Do thalidomides have a role in the treatment of multiple sclerosis? Sherbet, G.V. Sep 1, 2015 974
Relation of demographics and reported symptoms and medication use in persons with multiple sclerosis. Newland, Pamela; Riley, Marguerite; Foerster, Laura A.; Thomas, Florian P. Report Sep 1, 2015 4664
Roche announces positive results for ocrelizumab multiple sclerosis medicine. Financial report Jul 1, 2015 309
Roche announces positive results for ocrelizumab multiple sclerosis medicine. Financial report Jul 1, 2015 305
Naturopathic treatment for bowel incontinence in a patient with multiple sclerosis: a case study. Lorback, Sophie Report Jun 1, 2015 3740
New drugs could reverse nerve damage from multiple sclerosis; HEALTH NEWS. May 26, 2015 167
Genzyme wins US FDA approval for Lemtrada for the treatment of relapsing forms of multiple sclerosis. Nov 17, 2014 271
Genzyme wins US FDA approval for Lemtrada for the treatment of relapsing forms of multiple sclerosis. Nov 17, 2014 267
Pioneering drug trial in region to benefit multiple sclerosis sufferers. Sep 2, 2014 267
MS medicine approved for use in Wales. Aug 16, 2014 175
Hopes HIV drugs could help MS fight. Aug 5, 2014 125
Hopes HIV drugs could help MS fight. Aug 5, 2014 128
Dalfampridine helps walking ability in MS. McKnight, Whitney Clinical report Jun 1, 2014 289
Genzyme's Lemtrada sBLA reassigned US FDA's six-month review period for relapsing forms of multiple sclerosis. May 30, 2014 155
Genzyme's Lemtrada sBLA reassigned US FDA's six-month review period for relapsing forms of multiple sclerosis. May 30, 2014 159
Nerventra rejected by European Medicines Agency for treatment of relapsing-remitting multiple sclerosis. May 27, 2014 160
Nerventra rejected by European Medicines Agency for treatment of relapsing-remitting multiple sclerosis. May 27, 2014 156
Genzyme secures approval to market Lemtrada in Brazil for treatment of multiple sclerosis. Mar 24, 2014 280
Genzyme secures approval to market Lemtrada in Brazil for treatment of multiple sclerosis. Mar 24, 2014 276
Cholesterol Lowering Drug Slows Progression of Advanced Multiple Sclerosis. Mar 19, 2014 454
Genzyme reports approval & availibility of first-of-its-kind relapsing-remitting multiple sclerosis treatment in Canada. Feb 28, 2014 250
Genzyme reports approval & availibility of first-of-its-kind relapsing-remitting multiple sclerosis treatment in Canada. Feb 28, 2014 246
Genzyme wins COFEPRIS' approval for treatment of multiple sclerosis in Mexico. Feb 5, 2014 202
Genzyme's Lemtrada receives approval in Mexico for treatment of multiple sclerosis. Feb 5, 2014 241
Genzyme wins COFEPRIS' approval for treatment of multiple sclerosis in Mexico. Feb 5, 2014 198
Genzyme's Lemtrada receives approval in Mexico for treatment of multiple sclerosis. Feb 5, 2014 237
Teva Pharmaceutical Industries Ltd wins US FDA's approval for three-times-a-week COPAXONE 40mg/mL for treating relapsing forms of multiple sclerosis. Jan 29, 2014 215
Antioxidant drug reverses multiple sclerosis in mice. Dec 27, 2013 272
Genzyme's Lemtrada receives approval by Health Canada for treatment of multiple sclerosis. Dec 16, 2013 161
Genzyme's Lemtrada receives approval by Health Canada for treatment of multiple sclerosis. Dec 16, 2013 157
Discovery made in multiple sclerosis treatment. Disease/Disorder overview Nov 19, 2013 171
Study: pot not too hot for MS. Brief article Oct 1, 2013 138
Genzyme receives European Commission approval for Lemtrada for treatment of Multiple Sclerosis. Sep 18, 2013 223
Genzyme receives European Commission approval for Lemtrada for treatment of Multiple Sclerosis. Sep 18, 2013 219
Genzymea[euro](tm)s Aubagio approved by European Commission for Multiple Sclerosis treatment. Sep 2, 2013 179
Guideline for the diagnosis and management of multiple sclerosis: a Southern African perspective. Giampaolo, D. L.; Bhigjee, A.; Retief, C.; Isaacs, M.; Britz, M.; Opperman, D.; Govender, R.; van Re Report Sep 1, 2013 22747
GW Pharmaceuticals' multiple sclerosis spasticity study of Sativex indicates no long-term negative effect on cognition. Aug 6, 2013 145
GW Pharmaceuticals' multiple sclerosis spasticity study of Sativex indicates no long-term negative effect on cognition. Aug 6, 2013 141
Evidence backs medical marijuana for MS symptoms. Jancin, Bruce Aug 1, 2013 1073
Drug to treat MS could also help prevent heart failure. Jul 17, 2013 304
New treatments for multiple sclerosis. Jun 23, 2013 173
New ms therapy expands options. Bernstein, Sara Jun 22, 2013 536
Global Multiple Sclerosis Drugs Market Research Report Submitted by Transparency Market Research. Report May 17, 2013 528
Common multiple sclerosis drugs combination do not reduce relapse risk. Mar 31, 2013 583
Taking the sting out of injections. Wojcik, Emily Mar 22, 2013 1609
Aubagio: the road to approval and beyond. Mar 22, 2013 477
New drug target for treating multiple sclerosis and Alzheimer's identified. Jan 31, 2013 308
Clinical validation of a highly sensitive GC-MS platform for routine urine drug screening and real-time reporting of up to 212 drugs. Nair, Hari; Woo, Fred; Hoofnagle, Andrew N.; Baird, Geoffrey S. Report Jan 1, 2013 4491
Environmental medicine update: multiple sclerosis: environmental factors and treatments--Part 2. Marchese, Marianne Report Dec 1, 2012 2285
The association of depression with treatment and disability in multiple sclerosis/Multipl skleroz'da tedavi, ozurluluk ve depresyon arasindaki iliski. Tanik, Nermin; Aydin, Adem; Selvi, Yavuz; Gulec, Mustafa; Anlar, Omer; Tombul, Temel Report Dec 1, 2012 2825
Cancer drug introduces best treatment for multiple sclerosis. Nov 14, 2012 252
'Reboot' MS drug proves effective in trials. Nov 2, 2012 343
New multiple sclerosis treatment reduces relapses by about 50 percent. Nov 1, 2012 117
Drug trial results provide 'great news for people with MS'. Nov 1, 2012 189
Oral MS drug performs well: medication similar to one now used against psoriasis. Seppa, Nathan Oct 20, 2012 534
Oral MS drug approved with warning. Ault, Alicia Oct 1, 2012 373
Genzymea[euro](tm)s AUBAGIO approved by FDA as once-daily, oral treatment for relapsing Multiple Sclerosis. Sep 13, 2012 234
Genzymea[euro](tm)s AUBAGIO approved by FDA as once-daily, oral treatment for relapsing Multiple Sclerosis. Sep 13, 2012 230
Iran Breaks Israel's Monopoly by Producing MS Drug. Aug 30, 2012 189
FDA reports seizure risk with multiple sclerosis drug. Mechcatie, Elizabeth Aug 1, 2012 325
FDA reports seizure risk with multiple sclerosis drug. Mechcatie, Elizabeth Aug 1, 2012 376
NIH researchers implicate unique cell type in multiple sclerosis. Brief article Aug 1, 2012 121
Drug piloted in North to beat MS is available on the NHS. Jul 26, 2012 562
Now, single drug to treat Alzheimer's, multiple sclerosis and brain injury. Jul 25, 2012 567
The FDA warns about dangerous experimental treatment for MS. Jul 1, 2012 169
MS drug combo proves no better than monotherapy. Jul 1, 2012 390
Genzyme announces submission of sBLA to FDA and EMA for approval of LEMTRADA for Multiple Sclerosis. Jun 12, 2012 283
Potential new myelin repair treatment for multiple sclerosis. May 28, 2012 233
Biogen Idec's Oral BG-12 marketing applications for MS to be reviewed by US and EU authorities. May 10, 2012 179
Campaign for MS drug has paid off - now we're ready for next challenge; Columnist. May 2, 2012 512
MS pill to be made available to NHS patients. Mar 16, 2012 216
Hypertension drug offers hope. Brief article Feb 1, 2012 299
Opexaa[euro](tm)s Tovaxin for multiple sclerosis gets FDA Fast Track status. Nov 9, 2011 141
Persian spice saffron holds potential treatment for multiple sclerosis. Nov 5, 2011 289
-Analysts still voice doubts about Active Biotech's MS drug. Oct 26, 2011 337
-Analysts still voice doubts about Active Biotech's MS drug. Oct 26, 2011 338
Athersys collaborates on treatment for multiple sclerosis. Oct 24, 2011 384
Athersys Inc collaborates with Fast Forward LLC to develop MultiStem Multiple Sclerosis treatment. Oct 24, 2011 196
Allozyne reports encouraging Phase IB trial data on multiple sclerosis drug candidate. Oct 19, 2011 152
Systematic review of therapy for neurogenic detrusor overactivity. Fowler, Clare J. Report Oct 1, 2011 2454
Disease-modifying agents in progressive multiple sclerosis: management of 100 patients at Louis Stokes Cleveland VAMC, spinal cord injury division. Mangla, Saisho; Jain, Seema; Selkirk, Stephen Report Oct 1, 2011 4528
Watchdog rejects first pill to treat MS. Aug 5, 2011 105
Oral drug for multiple sclerosis gets licenced. Jul 26, 2011 528
Oman approves oral drug for multiple sclerosis. Jul 26, 2011 497
MS breakthrough could lead to drug treatment. Jun 27, 2011 136
Unique molecular mechanism offers new treatments for multiple sclerosis. Jun 22, 2011 194
Oral drug new hope for MS patients. May 10, 2011 237
Bahrain licences first MS oral drug. May 9, 2011 563
Biogen MS drug shows promise: Sanofi gains Menactra indication for infants. May 1, 2011 1621
Regulators give MS pill go-ahead. Apr 19, 2011 122
-Active Biotech, Teva announce final phase III results for MS drug. Clinical report Apr 12, 2011 250
-Active Biotech, Teva announce final phase III results for MS drug. Clinical report Apr 12, 2011 252
Safety data needed on MS drug. Mar 15, 2011 192
MS, mood swings and waterproof mascara. Zolotar, Kimberly Mar 15, 2011 821
The fuNny page: way back in 1980 something ... Hall, Mary Kathleen Essay Mar 15, 2011 649
Psoriasis drug may help in the fight against multiple sclerosis. Mar 9, 2011 327
Emerging oral therapies for multiple sclerosis. Miller, Colleen E.; Umhauer, Margaret A. Report Feb 1, 2011 7701
New Year's resolutions. Nelson, Joyce Dec 22, 2010 359
Fingolimod (Gilenya): how far will it go to treat MS? Drug overview Dec 22, 2010 1213
-Active Biotech, Teva unveil positive phase III results for MS drug. Dec 9, 2010 240
-Active Biotech, Teva unveil positive phase III results for MS drug. Dec 9, 2010 242
Cumulative corticosteroid doses and osteoporosis in patients with multiple sclerosis / Multipl sklerozlu hastalarda kumulatif kortikosteroid dozu ve osteoporoz. Arslan, Sule; Celiker, Reyhan; Karabudak, Rana Clinical report Dec 1, 2010 3328
Iran to Export MS Drug to Syria, Armenia, Russia. Nov 13, 2010 261
Bayer AG's (Leverkusen DEU) betaferon multiple sclerosis treatment helped patients live longer when taken soon after the onset of the disease in a study researchers said is the first to show such a drug extends patients' lives. Oct 18, 2010 387
First oral MS drug approved. Oct 15, 2010 193
First oral MS drug gets green light. Brief article Oct 15, 2010 193
Injectable disease-modifying therapy for relapsing-remitting multiple sclerosis: a review of adherence data. Caon, Christina; Saunders, Carol; Smrtka, Jennifer; Baxter, Nancy; Shoemaker, Jennifer Report Oct 1, 2010 3719
Factors that influence adherence and strategies to maintain adherence to injected therapies for patients with multiple sclerosis. Saunders, Carol; Caon, Christina; Smrtka, Jennifer; Shoemaker, Jennifer Report Oct 1, 2010 6757
Asthma medication may help multiple sclerosis patients. Sep 16, 2010 378
-Genmab unveils positive Phase II results for MS drug. Sep 13, 2010 238
Panel recommends novel MS drug. Brief article Jul 1, 2010 121
Panel likes novel MS drug. Brief article Jul 1, 2010 121
Cancer drug may help treat arthritis, multiple sclerosis. Jul 1, 2010 287
Tumour necrosis factor neutralization in MS: a cautionary tale. Arnason, B.G.W. Clinical report Jul 1, 2010 4177
New MS agent reduces relapse rate, disability. Splete, Heidi Jun 1, 2010 899
Novartis closer to first oral MS treatment. Apr 14, 2010 288
Collaboration on MS drug. Apr 1, 2010 214
Fampridine-SR may be first drug marketed for MS symptom. Brief article Mar 22, 2010 146
Cyclophosphamide Treatment of MS: current therapeutic approaches and treatment regimens. Elkhalifa, A.S.; Weiner, H.L. Report Mar 1, 2010 4786
Drug to aid walking in MS okayed. Brief article Feb 15, 2010 182
Oral agents for multiple sclerosis prove effective: discontinuation rates were low, but adverse event rates ranged from 8% to 14%. Moon, Mary Ann Feb 15, 2010 1035
FDA approves first drug to improve walking in MS patients. Mechcatie, Elizabeth Feb 15, 2010 363
Effect of oral antihistamine on local injection site reactions with self-administered glatiramer acetate. Pardo, Gabriel; Boutwell, Christine; Conner, Jill; Denney, Douglas; Oleen-Burkey, MerriKay Report Feb 1, 2010 4373
MULTIPLE BENEFITS; Pill boost for MS sufferers. Jan 21, 2010 263
New pill raises hopes for multiple sclerosis patients. Jan 21, 2010 144
Bayer says multiple sclerosis drug Betaferon approved in China. Dec 1, 2009 143
Fampridine gets backing for MS. Brief article Nov 1, 2009 240
Alemtuzumab. Bates, D. Editorial Nov 1, 2009 1146
Spotlight on Alemtuzumab. Jones, J.L.; Coles, A.J. Report Nov 1, 2009 3222
LOVE-SPLIT M.S. WOMAN TOOK HER OWN LIFE; Deadly drugs cocktail killed Fernanda. Oct 23, 2009 334
Mylan looks to take on Teva MS drug. Sep 28, 2009 353
MS sufferer bids to force trials of wonder drug that got him walking; GP says it's a wonderful cheap and safe treatment and very effective. Sep 21, 2009 715
Opexa Therapeutics Inc. Brief article Sep 14, 2009 148
Drug to help MS. Aug 24, 2009 207
Cheap BP drug could help treat multiple sclerosis. Aug 18, 2009 374
Blood pressure drug could help fight MS. Aug 18, 2009 153
Spotlight series: pivotal trials through today's knowledge--adrenocorticotrophic hormone. Sibley, W.A. Report Jul 1, 2009 3046
In the know: drug trial basics. Mofitt, Kevin Jun 22, 2009 496
In the pipeline: MS pills are moving from lab through clinical trials. Brief article Jun 22, 2009 236
Lower cost disease-modifying drugs? Cohen, Rose Jun 22, 2009 741
Identifying barriers to using an MS drug. Jun 22, 2009 494
FDA expands labeling for Copaxone. Brief article Jun 22, 2009 119
Diabetes drug found to provide protective effects against multiple sclerosis. May 27, 2009 389
Merck KGaA's multiple sclerosis pill cladribine cut patients' risk of relapsing in half even as it depleted white blood cells that protect the body from infection in some, a study showed. Brief article May 4, 2009 226
In other news pertaining to treatment of multiple sclerosis, Elan Corp Plc's Tysabri drug may be able to reverse damage caused by MS. Brief article May 4, 2009 148
MS pill to be on market soon. Apr 30, 2009 192
Pill to replace jab may offer hope to MS sufferers. Apr 30, 2009 376
New pill to replace painful multiple sclerosis jabs. Apr 30, 2009 309
CAM: low-dose naltrexone (LDN): the "411" on LDN. Bowling, Allen C. Drug overview Mar 22, 2009 1016
Funding the movement: Goodyear generations come together. Hubler, Eric Mar 22, 2009 674
Fast Forward supports novel therapy for MS. Brief article Mar 22, 2009 309
Is a clinical trial right for you? Brief article Mar 22, 2009 240
New drug transforms life of MS sufferer. Mar 6, 2009 245
Treatment/pipeline. Brief article Feb 1, 2009 172
All that is green is not always good. Bowling, Allen C. Report Dec 22, 2008 862
Stepping up to the plate for MS research. Richert, John R. Report Dec 22, 2008 833
Tysabri: two new cases of PML--and a label change. Brief article Dec 22, 2008 143
Treat multiple sclerosis early to boost outcomes. Zoler, Mitchel L. Report Nov 15, 2008 986
Multiple sclerosis improved with low-dose naltrexone. Zoler, Mitchel L. Nov 15, 2008 564
Specialist's hopes for new MS drug. Oct 27, 2008 236
WORLD TODAY: Drug may ease MS. Oct 23, 2008 124
Wonder drug in fight on MS; HEALTH: Leukaemia treatment may combat multiple sclerosis. Oct 23, 2008 352
MS drug gave me new hope; TEENAGER HAILS EFFECT OF TREATMENT. Oct 23, 2008 647
Cladribine tablets' potential in multiple sclerosis treatment. Costello, Kathleen; Sipe, Jack C. Oct 1, 2008 3590
Funding the movement: Dr. Agnes Varis makes connections. King, Martha Sep 22, 2008 701
The efficacy of citalopram in the treatment of postsroke pathological crying: a case report/Inme sonrasi patolojik aglama tedavisinde sitalopramin etkinligi: bir olgu sunumu. Ozturk, Zehra; Karakus, Gonca; Tamam, Lut Case study Sep 1, 2008 1709
KEEP USING IT; Two MS patients taking drug hit by brain disease, but company urges.. Aug 2, 2008 323
Impact of warm compresses on local injection-site reactions with self-administered glatiramer acetate. Jolly, Helen; Simpson, Kellie; Bishop, Barbara; Hunter, Heli; Newell, Cassie; Denney, Douglas; Oleen Aug 1, 2008 5863
Tysabri in the news. Brief article Jun 22, 2008 225
Society publishes opinion paper on marijuana. Jun 22, 2008 406
Oral multiple sclerosis drug provides sustained efficiency. Wendling, Patrice May 15, 2008 431
Hepatotoxicity reported with natalizumab therapy. Mechcatie, Elizabeth Apr 1, 2008 480
Help from MS drug makers. Boerner, Heather Mar 22, 2008 988
Hepatotoxicity noted with natalizumab. Mechcatie, Elizabeth Mar 15, 2008 455
The 23rd Congress of the European Committee for Treatment and Research in Multiple Sclerosis: 12th Annual Conference of Rehabilitation in MS Congress, Prague, Czech Republic, 11-14 October 2007. Clanet, Michel Conference news Mar 1, 2008 1240
Cancer drug limits MS relapses. Seppa, Nathan Brief article Feb 23, 2008 243
MS treatment plus antibiotic 'could slow down disease'. Clinical report Dec 11, 2007 358
Drug to limit MS agony. Aug 3, 2007 84
Expert hits out over MS drug hitch. Jul 23, 2007 362
Warning over MS drug's delay. Jul 23, 2007 196
Natalizumab might cut visual loss risk. Brief article May 15, 2007 277
Vitamin D may reduce MS risk. Brief article Jan 8, 2007 149
Aricept, Betaseron. Mechcatie, Elizabeth Dec 15, 2006 590
Tysabri[R] OK for MS. Dec 1, 2006 737

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters